Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Care of Patients with Follicular Lymphoma (Symposium Video Proceedings) Proceedings from a live event on September 5, 2025, held in conjunction with the Society of Hematologic Oncology 2025 Annual Meeting and moderated by Dr Jeremy S Abramson. Featuring perspectives from Dr Jeremy S Abramson, Dr Jennifer Crombie and Dr Laurie H Sehn, moderated by Dr Abramson. Published October 2025. Topics: • Introduction (0:00) • Integrating Bispecific Antibodies into the Management of Follicular Lymphoma (FL) — Dr Crombie (2:08) • ICurrent Role of CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for FL — Dr Abramson (21:01) • Other Recently Approved and Emerging Novel Therapies for Relapsed/Refractory FL — Dr Sehn (40:52) The complete program, slides, CME information, and selected publications: https://www.researchtopractice.com/SO...